BOVI dekker høyfrekvente mobilitetsbehov i og rundt by- og stedskjernen med trygge, miljøvennlige og brukerorienterte løsninger tilpasset offentlige og andre strategiske relasjoners behov. Bovi mobilitet tilbyr et konsept som ivaretar dagens opplevde problemer knyttet til mikromobilitet, Hastighetsregulering, Ryddig parkering, Trygghet og sikkerhet, Miljø, og bærekraft Automatisk hastighetsregulering. Behovsprøvet og regulert parkering Trygg og sikker mobilitet

Secundo is on its way to becoming a leading European marketplace for recommerce. Since its establishment, we have had enormous growth in Norway, and we are currently expanding in Europe. We have a healthy economy with a focus on profitable operations. In addition, we have a strategic and skilled board with experienced entrepreneurs and investors. Read more: https://netthandel.no/denne-gjengen-skal-ta-den-ai-styrte-markedsplassen-til-utlandet https://www.shifter.no/nyheter/secundos-ai-styrte-bruktsalg-har-tredoblet-omsetningen-det-siste-halvaret/279980 https://www.finansavisen.no/lordag/gruenderintervjuet/2022/01/28/7807154/markedsplassen-secundo-vil-gjore-kjop-og-salg-enklere-med-algoritmer

Kengle er en spennende start-up som spinner ut fra by- og konseptutviklingsselskapet Cityplan. Vi har kompetente og meritterte teknologer i ulike felt, sammen med vårt kreative team av konseptutviklere innenfor ulike eiendoms- og servicerelaterte konsepter. Vi kommer fra et kreativt miljø som beveger oss raskt, er svært beslutningsdyktig og har alltid gjort ting på vår måte.

Humans for Humans is a non-governmental organization that provides free mental health support for human trafficking survivors, those indirectly affected by human trafficking, and the professionals who work with them. Moreover, we aim to promote the anti-trafficking movement and contribute to the awareness and eradication of modern slavery.

Orca is navigation for the modern boater. Tesla changed the way we view in-car navigation and infotainment. Orca is doing the same for boats – from software to hardware and marine mapping. Orca is used by boaters worldwide, onboard RIBs, day cruisers, and sailboats. Some use the Orca Core to unlock powerful navigation features on their tablet and phone. Others get the marine-grade Orca Display for a robust and reliable experience in demanding conditions. No matter what you want, you can be sure you’ll get a truly modern, powerful, and incredible navigation experience with Orca. Learn more at getorca.com

SonoClear AS develops an acoustic contrast fluid to remove noise in ultrasound images, used during brain tumor surgery to guide tumor removal. The goal is to be sure that all tumor is removed, as total resection improves patient outcomes. The technology is developed by neurosurgeons at St.Olavs hospital and engineers at Sintef. The technology is patented worldwide and is developed as a medical device according to ISO13485. The core team consists of CTO, Medical advisor, Quality manager, and Regulatory officer. SonoClear plan for market access in USA and EU in 4q20 and 4q21, respectively.

BabySensor is developing a new unique monitor that measures the most important factors for a baby's health and well-being. It is the only product of its type monitoring heartbeat, temperature, lying position and baby’s cry. It is based on ground-breaking research and provides valuable information to parents through a mobile app. Safety is a high priority for families, and the trend shows a growing market within baby monitoring systems. We have a reliable, competent and experienced team who will succeed in turning the prototype into an attractive product.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

Modern, nobel-prize winning research shows that hardly any traditional investment funds are adding any value beyond what fully automated strategies can do. NorQuant's mission is to help private and professional investors achieve higher returns at lower costs through a scientific, rules-based, 100% transparent approach. We feel we are off to a good start: - We are helping our first pilot customer, one of Norway's largest family offices, implement factor-based analysis - We have been selected as one of ten fintech-startups for TheFactory.no Fall18 program, out of more than 200 applications

Bemanning er en viktig del av en butikksjefs ansvarsområde. For få ansatte på jobb i forhold til behov vil man miste potensielle salgsmuligheter, og overbemanning vil resultere i at lønnskostnader spiser opp dagens inntjening. Selv om viktigheten av korrekt bemanning er åpenbar, blir det meste av planlegging ofte gjennomført på et mangelfullt datagrunnlag, og i enkelte tilfeller basert på magefølelse. Kunder stiller stadig strengere krav til tilgjengelighet og service, noe som vil føre til at dagens begrensede form for butikkdrift vil tape kampen mot smarte, digitaliserte løsninger

We are a team of dedicated scientists, engineers and designers with competence in computer vision, advanced robotics and edge AI. Bergen Robotics has developed an advanced autonomous payload for power-line inspections. The payload can shoot detailed images of specific components at high speed and fully based on onboard AI. The technology is now working and has found a new home at Haawk. AI. Bergen Robotics also own part of the med-tech company Flyt Medical AS and is responsible for technical development. Bergen Robotics can do consulting work provided that the work includes at least two of the following areas: - AI/Computer Vision - Robotics - Camera systems Send us a message or call for inquiries!

Ose Water AS is a Norwegian bottled water and bag-in-box water producer.The water source is Ose which provides high quality natural mineral water. The company aim to be in production for international sale in Q1 2019. Ose Water AS is a producer of natural mineral water from the Ose spring in Bygland municipality, Aust-Agder county in Norway.

Forretningsidé Tenk hvor mye ubenyttet kunnskap vi har. Fromber er en digital plattform for privatundervisning som gjennom ny teknologi og forretningsmodell tilbyr billigere, lettere tilgjengelig og større effekt av det du ønsker å lære mer av. Med Fromber kan du som bruker lære mer og som talent hjelpe andre å bli bedre, med formål om å ta ett skritt frem med en som er ett skritt foran. Fromber er derfor både et marked som verdsetter din kunnskap og et sentrum for læring. Mål: Bli sentrum for all privatundervisning i Norge, for så å ekspandere til Norden. Deretter Europa og tilslutt å innta en identisk posisjon som Uber har for taxi, gjennom privatundervisning, tilgjengelig for mennesker i alle deler av verden. Visjon: Fromber har en visjon om å gjøre privatundervisning tilgjengelig for alle.

Entro is an energy- and environmental consultancy firm with two clients – our customers and the environment. We save our customers time and money, and we help the environment by reducing energy consumption and carbon footprints. Entro has about 60 employees in Oslo, Trondheim, and Bergen. We had a turnover of NOK 63 million in 2016 and saved our customers NOK 400 million. Entro has a unique interdisciplinary expertise with a good mix of practical and academic skills. Among our staff we have more trade certificates in electrical and construction, more than 60% of the employees are civil engineers and engineers and we have several employees with training in economics and management. We have expertise in electrical, plumbing, building, environment, and IT.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology